Jeff Del Carmen

Biography

Jeff joined Catalyst in 2018 as SVP, Sales and Marketing and was named EVP, Chief Commercial Officer in June 2020. Working for almost two decades in the neurology orphan disease space, Jeff saw an opportunity at Catalyst to help people with rare diseases access innovative treatments that could meet urgent needs.

“Working at the intersection of patient access and meeting the needs of shareholders. At Catalyst, we live the credo “no patient left behind.” We have a fundamental belief that if a person is prescribed our medicine, they will receive our medicine regardless of ability to pay. Catalyst is proof that you can have a successful business while ensuring patients get treatments when and where they need them.”

Other Notable Roles:
SVP, Business Development, Paragon Biosciences
Senior Director, Rare Disease Marketing, Marathon Pharmaceuticals
VP, Sales, Insys Therapeutics
National Sales Director, Movement Disorders and Regional Business Director, Neurology, Lundbeck
Sales/Marketing, Abbott Laboratories

Degrees:
Bachelor of Art, Economics, University of Dayton
Executive MBA, University of Wisconsin-Madison